Prosecution Insights
Prosecution Insights
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (80%) |
| §102 only | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAYNES, DAWN TRINAH | 1 | 2.9% | +0.7% |
| AL-AWADI, DANAH J | 1 | 53.6% | +14.0% |
| TURPIN, ZACHARY MARK | 1 | 0.0% | +0.0% |
| SHIN, MONICA A | 1 | 50.3% | +47.0% |
| WESTON, ALYSSA G | 1 | 63.0% | +49.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18247474 | RAPID DIAGNOSTIC ELECTROCHEMICAL BIOSENSING TARGETED WITH ANTISENSE OLIGONUCLEOTIDES | TURPIN, ZACHARY MARK | 19d |
| 18583009 | METHODS, SYSTEMS, AND DEVICES FOR ANALYZING OBJECTIVE HEALTH DATA AND SUBJECT-CONVEYED HEALTH INFORMATION FOR HEALTH INFORMATION REPORTING, TREATMENT PLANNING, DIAGNOSES, AND TREATMENT | HAYNES, DAWN TRINAH | 40d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17176422 | APPARATUS FOR SEPARATING THE CELLULAR AND LIQUID PORTIONS OF A WHOLE BLOOD SAMPLE | WESTON, ALYSSA G | 18d overdue |
| 18299135 | ON DEMAND AND LONG-TERM DRUG DELIVERY FROM DEGRADABLE NANOCAPSULES | AL-AWADI, DANAH J | 14d |
| 18040439 | ENGINEERING DIVERSE ANTIGEN-PRESENTING CELLS TO CONTROL ANTIGEN-SPECIFIC RESPONSES | SHIN, MONICA A | 41d |
| Art Unit | Apps |
|---|---|
| 3686 | 1 |
| 1615 | 1 |
| 1682 | 1 |
| 1616 | 1 |
| 1633 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18583009 | METHODS, SYSTEMS, AND DEVICES FOR ANALYZING OBJECTIVE HEALTH DATA AND SUBJECT-CONVEYED HEALTH INFORMATION FOR HEALTH INFORMATION REPORTING, TREATMENT PLANNING, DIAGNOSES, AND TREATMENT | HAYNES, DAWN TRINAH | 3686 | §103 | Non-Final OA | 40d | Pending | Feb 21, 2024 |
| 18299135 | ON DEMAND AND LONG-TERM DRUG DELIVERY FROM DEGRADABLE NANOCAPSULES | AL-AWADI, DANAH J | 1615 | §103 | Non-Final OA | 14d | Pending | Apr 12, 2023 |
| 18247474 | RAPID DIAGNOSTIC ELECTROCHEMICAL BIOSENSING TARGETED WITH ANTISENSE OLIGONUCLEOTIDES | TURPIN, ZACHARY MARK | 1682 | §103 | Non-Final OA | 19d | Pending | Mar 31, 2023 |
| 18040439 | ENGINEERING DIVERSE ANTIGEN-PRESENTING CELLS TO CONTROL ANTIGEN-SPECIFIC RESPONSES | SHIN, MONICA A | 1616 | §103 | Non-Final OA | 41d | Pending | Feb 03, 2023 |
| 17176422 | APPARATUS FOR SEPARATING THE CELLULAR AND LIQUID PORTIONS OF A WHOLE BLOOD SAMPLE | WESTON, ALYSSA G | 1633 | §102 | Final Rejection | 18d overdue | Pending | Feb 16, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial